Profil
Jane Hughes is the founder of Verdiva Bio Ltd., founded in 2024, holding the title of President, Head-Research & Development.
Dr. Hughes is also the founder of Verdiva Bio, Inc...
Dr. Hughes is Chief Scientific Officer at Gyroscope Therapeutics Holdings Plc since 2019.
Formerly, Dr. Hughes was Senior Director-Integrated Drug Discovery at Charles River Laboratories, Inc. from 2017 to 2018 and Director-Discovery Medicine & Immuno Inflammation at GSK Plc from 2014 to 2017.
Dr. Hughes earned a doctorate from Keele University.
Postes actifs de Jane Hughes
| Sociétés | Poste | Début |
|---|---|---|
| GYROSCOPE THERAPEUTICS HOLDINGS PLC | Directeur Technique/Scientifique/R&D | 01/10/2019 |
Anciens postes connus de Jane Hughes
| Sociétés | Poste | Fin |
|---|---|---|
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research models and laboratory animal support services | Corporate Officer/Principal | 01/11/2018 |
| GSK PLC | Corporate Officer/Principal | 01/06/2017 |
Formation de Jane Hughes
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Charles River Laboratories, Inc.
Charles River Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Provides research models and laboratory animal support services | Commercial Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Keele University
Keele University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Gyroscope Therapeutics Holdings Plc
Gyroscope Therapeutics Holdings Plc BiotechnologyHealth Technology Develops clinical-stage gene therapies to treat diseases of eyes | Health Technology |
















